Advertisement

Topics

Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

18:54 EDT 26th March 2017 | BioPortfolio

PubMed Articles [392 Associated PubMed Articles listed on BioPortfolio]

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Presenting With Unilateral Purtscherlike Retinopathy.

Ophthalmic Screening Patterns Among Youths With Diabetes Enrolled in a Large US Managed Care Network.

Ophthalmic screening to check for diabetic retinopathy (DR) is important to prevent vision loss in persons with diabetes. The American Academy of Ophthalmology recommends that ophthalmic screening for...

Diabetic Retinopathy Screening With Telemedicine: A Potential Strategy to Engage Our Youth.

A systematic review on the impact of diabetes mellitus on the ocular surface.

Diabetes mellitus is associated with extensive morbidity and mortality in any human community. It is well understood that the burden of diabetes is attributed to chronic progressive damage in major en...

Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study.

The purpose of this prospective study was to investigate the potential risk factors associated independently with central serous retinopathy (CSR) in a Greek population, using multivariate approach.

Quantification of Retinal Microvascular Density in Optical Coherence Tomographic Angiography Images in Diabetic Retinopathy.

Quantitative measurements based on optical coherence tomographic angiography (OCTA) may have value in managing diabetic retinopathy (DR), but there is limited information on the ability of OCTA to dis...

Retinopathy of prematurity in Indonesia: Incidence and risk factors.

Retinopathy of prematurity (ROP) is a vaso-proliferative disease of the eye, which mainly affects preterm newborn infants with an incompletely vascularized retina. The incidence of ROP has increased i...

Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

To determine the association between skin intrinsic fluorescence (SIF), a noninvasive measure of advanced glycation endproducts and oxidative stress in skin, and retinal microvascular complications of...

Combined Laser Photocoagulation and anti-VEGF Injection Treatment in Radiation Retinopathy.

Background Radiation retinopathy can lead to a considerable reduction in visual acuity. We report 2 cases of radiation retinopathy in which a therapy with combined intravitreal anti-VEGF injection and...

Hydroxychloroquine retinopathy.

Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncol...

News Articles [138 Associated News Articles listed on BioPortfolio]

Many youths with diabetes not monitored for diabetic retinopathy by 6 years after diagnosis

Many youths with a diagnosis of diabetes do not receive eye examinations to screen for diabetic retinopathy within 6 years of their diagnosis, according to a study. A retrospective, longitudinal cohor...

Many Kids With Diabetes Missing Out on Eye Exams, Study Finds

THURSDAY, March 23, 2017 -- Many young Americans with diabetes aren't getting the eye exams that medical experts say they need, new research reveals. "Diabetic retinopathy" is a serious complication o...

Many youths with diabetes not being screened as recommended for diabetic retinopathy

Many youths with type 1 and 2 diabetes are not receiving eye examinations as recommended to monitor for diabetic retinopathy, according to a study published online by JAMA Ophthalmology.

Diabetic Youth Don't Get Screened for Eye Complication (CME/CE)

(MedPage Today) -- Guidelines for diabetic retinopathy not being followed

PUBLICATION EXCLUSIVE: ASCRS Research Council aims to mirror success of DRCR.net

The Diabetic Retinopathy Clinical Research Network is a collaboration among the National Eye Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, industry and more than 400...

Optical Coherence Tomographic Angiography Helps Track Diabetic Retinopathy

Vessel density as measured by optical coherence tomographic angiography (OCTA) correlates with the severity of diabetic retinopathy (DR) and may yield insight beyond that provided by fundus photograph...

Study suggests new way to prevent vision loss in diabetics and premature babies

(Rockefeller University Press) Researchers at Bascom Palmer Eye Institute, part of the University of Miami Miller School of Medicine, have identified a new molecule that induces the formation of abnor...

Now-public Aerpio Pharmaceuticals raises $40mm privately

Aerpio Therapeutic, Inc. and Aerpio Acquisition Corp. have reverse merged to form publicly traded Aerpio Pharmaceuticals Inc., which concurrently raised $40mm through the sale of 8mm common shares at ...

Ophthalmology Devices Global Market Forecast To 2021 [Updated: 03072015] Prices from USD $4500

Ophthalmology is a segment of medical science associated with study of anatomy, physiology, diseases of human eye, and developing various therapeutic methods to treat eye diseases. Some of the major e...

ThromboGenics Business Update - FY 2016

LEUVEN, Belgium, March 16, 2017 /PRNewswire/ -- - Innovative Diabetic Eye Disease Clinical and Pre-Clinical Portfolio - Provides "Multiple Shots on Goal"   - First Patients Enrolled i...

Events [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is ...

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [254 Associated Clinical Trials listed on BioPortfolio]

The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo

The purpose is to investigate how the adenosine affects the diameter regulation of retinal arterioles during changes in oxygen tension. A deeper understanding of the mechanisms involved in...

Intravitreal Aflibercept Injection for Radiation Retinopathy Trial

The ARRT trial will assess the safety and efficacy of 2mg aflibercept for the treatment of radiation retinopathy, including maculopathy and optic neuropathy over 52 weeks.

Propranolol for Prevention of Threshold Retinopathy of Prematurity

Extremely premature infants are at risk of developing a potentially blinding eye disease, called retinopathy of prematurity (ROP). Currently available treatment, consisting of laser surger...

The PUPIL Study - Automated, Quantitative Pupil Assessment Using Binocular OCT

In current, clinical ophthalmology, a range of specialised testing allows comprehensive evaluation of ocular health. These tests have typically evolved over many years to ensure their clin...

Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool

More than 29 million people in the US are living with diabetes, many of whom will develop diabetic retinopathy (DR) or diabetic eye disease (DED), the leading cause of vision loss and blin...

A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)

This study is conducted to evaluate the safety of THR-317 when administered intravitreally and to assess the compound's efficacy in improving best-corrected visual acuity (BCVA) and reduci...

Antioxidant Use in Diabetes to Reduce Oxidative Stress

Dietary supplementation with antioxidant vitamins, such as Vitamin C and Vitamin E, reduces malformation rates in embryos of diabetic animals. However, human trials exploring the benefits ...

a Prospective Cohort Study for Propranolol Treatment in Retinopathy of Prematurity

The purpose of this study is to evaluate the safety and efficacy of oral/local propranolol in preterm newborns who diagnosed as early phase of retinopathy of prematurity (ROP).

Determination of Cut-off Value of AGEsP and HbA1c in Type 2 Diabetes Diagnosis in China

Study of the correlation between AGEsP and HbA1c and diabetic retinopathy prevalence: determination of cut-off value of AGEsP and HbA1c in type 2 diabetes diagnosis in China

Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

This study include 384 Participants with diabetic non-proliferative retinopathy Design Method: Randomized, double blind, placebo controlled and multicenter clinical study. Participants tr...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Quick Search
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks